Man Group PLC Catalyst Biosciences, Inc. Transaction History

Man Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$4.1 - $5.33 $63,959 - $83,148	-15,600 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.93 - $7.15 $214,455 - $311,025	-43,500 Reduced 73.6%	15,600 $79,000
Q4 2020 Feb 16, 2021	BUY	$4.55 - $7.29 $24,115 - $38,637	5,300 Added 9.85%	59,100 $373,000
Q3 2020 Nov 16, 2020	BUY	$4.22 - $6.04 $60,346 - $86,372	14,300 Added 36.2%	53,800 $231,000
Q2 2020 Aug 14, 2020	BUY	$3.76 - $8.01 $148,520 - $316,395	39,500 New	39,500 $232,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.